Page last updated: 2024-09-02

5-chloro-8-hydroxy-3,4-dihydro-3-methylisocoumarin-7-carboxylic acid and Kidney Diseases

5-chloro-8-hydroxy-3,4-dihydro-3-methylisocoumarin-7-carboxylic acid has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barriault, C; Bouchard, G; Frohlich, AA; Kerkadi, A; Marquardt, RR; Tuchweber, B; Yousef, IM1

Other Studies

1 other study(ies) available for 5-chloro-8-hydroxy-3,4-dihydro-3-methylisocoumarin-7-carboxylic acid and Kidney Diseases

ArticleYear
Dietary cholestyramine reduces ochratoxin A-induced nephrotoxicity in the rat by decreasing plasma levels and enhancing fecal excretion of the toxin.
    Journal of toxicology and environmental health. Part A, 1998, Feb-06, Volume: 53, Issue:3

    Topics: Acetylglucosaminidase; Animal Feed; Animals; Anion Exchange Resins; Bile; Bile Acids and Salts; Cholestyramine Resin; Dose-Response Relationship, Drug; Feces; Food Contamination; Glutathione Transferase; Kidney; Kidney Diseases; Male; Mycotoxins; Ochratoxins; Rats; Rats, Sprague-Dawley

1998